Approval · Notice of Compliance 3741 · 1997
PROSTIN E2: Notice of Compliance 3741
Issued September 4, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3741
- Date
- September 4, 1997
- Company
- Pharmacia & Upjohn Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Prostaglandin
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROSTIN E2 | 01919679 | Cancelled Post Market |
| PROSTIN E2 | 01919687 | Cancelled Post Market |
Medicinal ingredients
- DINOPROSTONE 1 MG per 3G
- DINOPROSTONE 2 MG per 3G